...
首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Serum proteomic profiling in patients with drug-induced liver injury
【24h】

Serum proteomic profiling in patients with drug-induced liver injury

机译:药物性肝损伤患者的血清蛋白质组学分析

获取原文
获取原文并翻译 | 示例
           

摘要

Idiosyncratic drug-induced liver injury (DILI) is a complex disorder that is difficult to predict, diagnose and treat.
机译:特异性药物性肝损伤(DILI)是一种复杂的疾病,难以预测,诊断和治疗。

著录项

  • 来源
    《Alimentary Pharmacology & Therapeutics》 |2012年第5期|600-612|共13页
  • 作者单位

    Division of Gastroenterology/Hepatology Indiana University Indianapolis IN USA;

    Department of Internal Medicine University of North Carolina at Chapel Hill Chapel Hill NC USA;

    Cannon Research Center and Center for Liver and Digestive Diseases Carolinas Medical Center Charlotte NC USA;

    Department of Internal Medicine University of Connecticut Farmington CT USA;

    Liver Disease Research Branch NIH/NIDDK Bethesda MD USA;

    Department of Internal Medicine University of Michigan Ann Arbor MI USA;

    Protein Analysis Research Center Indiana University Indianapolis IN USA;

    Duke Clinical Research Institute Durham NC USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号